Trial Profile

Pharmacokinetics of Levonorgestrel and Ulipristal Acetate Emergency Contraception in Women With Normal and Obese Body Mass Index

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ulipristal (Primary) ; Levonorgestrel
Indications Pregnancy
Focus Pharmacokinetics

Most Recent Events

30 Jun 2017 Status changed from active, no longer recruiting to completed.
23 Jan 2017 Results comparing the pharmacokinetics of levonorgestrel and ulipristal acetate between normal-BMI and obese-BMI women, published in the Contraception.
28 Sep 2016 Planned End Date changed from 1 Jun 2016 to 1 Mar 2017.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com